Gary Milkovich

586 total citations
26 papers, 423 citations indexed

About

Gary Milkovich is a scholar working on Pharmacology, Epidemiology and Hematology. According to data from OpenAlex, Gary Milkovich has authored 26 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Epidemiology and 6 papers in Hematology. Recurrent topics in Gary Milkovich's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Antibiotic Use and Resistance (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Gary Milkovich is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Antibiotic Use and Resistance (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Gary Milkovich collaborates with scholars based in United States, Germany and France. Gary Milkovich's co-authors include Gene A. Gibson, Thomas M. File, Stephen Brunton, Daniel F. Sahm, Keith A. Rodvold, Alpesh Amin, Thomas G. Slama, Joseph Varón, David Weiland and Darell Heiselman and has published in prestigious journals such as Blood, The American Journal of Medicine and Drugs.

In The Last Decade

Gary Milkovich

26 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Milkovich United States 13 87 80 66 64 61 26 423
Tim T Y Lau Canada 15 96 1.1× 147 1.8× 72 1.1× 38 0.6× 77 1.3× 35 573
Y. Valcke Belgium 11 205 2.4× 207 2.6× 38 0.6× 30 0.5× 72 1.2× 23 553
Rocsanna Namdar United States 10 128 1.5× 103 1.3× 20 0.3× 34 0.5× 43 0.7× 16 513
Winfried V. Kern Germany 13 179 2.1× 75 0.9× 151 2.3× 25 0.4× 156 2.6× 24 655
Eyal Braun Israel 12 245 2.8× 34 0.4× 58 0.9× 18 0.3× 139 2.3× 36 669
R. van Dalen Netherlands 10 207 2.4× 140 1.8× 32 0.5× 17 0.3× 37 0.6× 15 593
Csaba Fehér Spain 14 190 2.2× 157 2.0× 104 1.6× 16 0.3× 51 0.8× 23 482
Donna Capozzi United States 5 87 1.0× 127 1.6× 90 1.4× 20 0.3× 34 0.6× 10 430
María Martín Cerezuela Spain 11 69 0.8× 31 0.4× 51 0.8× 13 0.2× 31 0.5× 21 383
Willem L. Blok Netherlands 15 210 2.4× 38 0.5× 56 0.8× 24 0.4× 43 0.7× 32 1.0k

Countries citing papers authored by Gary Milkovich

Since Specialization
Citations

This map shows the geographic impact of Gary Milkovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Milkovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Milkovich more than expected).

Fields of papers citing papers by Gary Milkovich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Milkovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Milkovich. The network helps show where Gary Milkovich may publish in the future.

Co-authorship network of co-authors of Gary Milkovich

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Milkovich. A scholar is included among the top collaborators of Gary Milkovich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Milkovich. Gary Milkovich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arinsburg, Suzanne, Tomer M. Mark, Christopher A. Fausel, et al.. (2024). Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma. Bone Marrow Transplantation. 59(10). 1440–1448. 1 indexed citations
2.
3.
Hübel, Kai, Helmut Ostermann, Bertram Glaß, et al.. (2018). Plerixafor in non-Hodgkin’s lymphoma patients: a German analysis of time, effort and costs. Bone Marrow Transplantation. 54(1). 123–129. 9 indexed citations
4.
Mohty, Mohamad, Nabih Azar, Christian Chabannon, et al.. (2017). Plerixafor in poor mobilizers with non-Hodgkin’s lymphoma: a multi-center time-motion analysis. Bone Marrow Transplantation. 53(3). 246–254. 23 indexed citations
5.
Esposito, Silvano, Simona Purrello, É. Bonnet, et al.. (2013). Central venous catheter-related biofilm infections: An up-to-date focus on meticillin-resistant Staphylococcus aureus. Journal of Global Antimicrobial Resistance. 1(2). 71–78. 29 indexed citations
6.
7.
Milkovich, Gary. (2009). Future pharmacoeconomic criteria for the treatment of infections. International Journal of Antimicrobial Agents. 34. S12–S14. 2 indexed citations
8.
Cantón, Rafael, H. Lode, W. Graninger, & Gary Milkovich. (2006). Respiratory tract infections: at-risk patients, who are they?Implications for their management with levofloxacin. International Journal of Antimicrobial Agents. 28. S115–S127. 12 indexed citations
9.
File, Thomas M., Gary Milkovich, Alan M. Tennenberg, et al.. (2004). Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia. Current Medical Research and Opinion. 20(9). 1473–1481. 26 indexed citations
10.
Beveridge, Roy, et al.. (2003). Impact of Long‐Acting Growth Factors on Practice Dynamics and Patient Satisfaction. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(12P2). 101S–109S. 33 indexed citations
11.
Milkovich, Gary. (2001). Intravenous‐to‐Oral Transition Therapy in Community‐Acquired Pneumonia: The INOVA Health System Experience. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(7P2). 13 indexed citations
12.
Milkovich, Gary. (2000). The role of the hospital pharmacist in cost control and antibiotic policy. International Journal of Antimicrobial Agents. 16(3). 291–294. 5 indexed citations
13.
Milkovich, Gary, et al.. (2000). Comparative Safety of Filgrastim versus Sargramostim in Patients Receiving Myelosuppressive Chemotherapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(12). 1432–1440. 17 indexed citations
14.
Milkovich, Gary. (1996). Antibiotic Usage: Pharmacoeconomic Impact in a Changing Healthcare System. Drugs. 52(Supplement 2). 80–82. 3 indexed citations
15.
Milkovich, Gary. (1995). Benefits of outpatient parenteral antibiotic therapy: to the individual, the institution, third-party payers and society. International Journal of Antimicrobial Agents. 5(1). 27–31. 14 indexed citations
16.
Milkovich, Gary. (1995). Clinical Paths: Tools for Outcomes Management. American Journal of Health-System Pharmacy. 52(15). 1723–1723. 4 indexed citations
17.
Milkovich, Gary. (1993). Costs and Benefits. Hospital Practice. 28(sup1). 39–43. 10 indexed citations
18.
Heiselman, Darell, et al.. (1993). Nasointestinal Tube Placement With a pH Sensor Feeding Tube. Journal of Parenteral and Enteral Nutrition. 17(6). 562–565. 26 indexed citations
19.
Milkovich, Gary, et al.. (1991). Considerations in Comparing Intravenous and Intramuscular Antibiotics. Chemotherapy. 37(2). 1–13. 5 indexed citations
20.
Milkovich, Gary, et al.. (1986). Acyclovir. Infection Control. 7(4). 228–229. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tim T Y Lau Breakdown of academic impact, for papers by Y. Valcke Breakdown of academic impact, for papers by Rocsanna Namdar Breakdown of academic impact, for papers by Winfried V. Kern Breakdown of academic impact, for papers by Eyal Braun Breakdown of academic impact, for papers by R. van Dalen Breakdown of academic impact, for papers by Csaba Fehér Breakdown of academic impact, for papers by Donna Capozzi Breakdown of academic impact, for papers by María Martín Cerezuela Breakdown of academic impact, for papers by Willem L. Blok
Rankless by CCL
2026